Prevalence and Clinical Implications of Epstein–Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries - Ok, Chi Young; Li, Ling; Xu-Monette, Zijun Y.; Visco, Carlo; Tzankov, Alexander; Manyam, Ganiraju C.; Montes-Moreno, Santiago; Dybaer, Karen; Chiu, April; Orazi, Attilio; Zu, Youli; Bhagat, Govind; et al. (Clinical cancer research, 2014)
Keywords: Adult; Aged; Antibodies, Monoclonal, Murine-Derived - therapeutic use; Antineoplastic agents; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biological and medical sciences; Cluster Analysis; Cyclophosphamide - therapeutic use; Developed Countries - statistics & numerical data; Doxorubicin - therapeutic use; Epstein-Barr Virus Infections - complications; Female; Gene Expression Profiling; Hematologic and hematopoietic diseases; Humans; Infectious diseases; Ki-1 Antigen - metabolism; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Lymphoma, Large B-Cell, Diffuse - diagnosis; Lymphoma, Large B-Cell, Diffuse - drug therapy; Lymphoma, Large B-Cell, Diffuse - epidemiology; Lymphoma, Large B-Cell, Diffuse - etiology; Male; Medical sciences; Middle Aged; Neoplasm Staging; NF-kappa B - metabolism; Pharmacology. Drug treatments; Phosphorylation; Prednisone - therapeutic use; Prevalence; Survival Analysis; Treatment Outcome; Tumor Burden; Vincristine - therapeutic use; Viral diseases; Gammaherpesvirinae; Prevalence; Herpesviridae; B cell neoplasm; Malignant hemopathy; Epstein Barr virus; Non Hodgkin lymphoma; Epidemiology; De novo; Infection; Virus; Western countries; Lymphoproliferative syndrome; Viral disease; Diffuse large B cell lymphoma; Cancer